Investment
Features
FeesSafety
Academy
More
Pluang+

Coherus Oncology to release interim clinical data on tagmokitug for solid tumors on Oct 28, 2026

Market News
14 Oct 2026
GlobeNewsWire
View Source
Neutral
Coherus Oncology to release interim clinical data on tagmokitug for solid tumors on Oct 28, 2026

Coherus Oncology announced it will disclose interim clinical data for tagmokitug, a cytolytic CCR8 antibody combined with toripalimab, targeting multiple solid tumors. The data release is scheduled for October 28, 2026, with a webcast hosted by company management and key opinion leaders to discuss the findings. This update is significant as tagmokitug is in Phase 1b/2a trials for advanced cancers including head and neck, colorectal, gastric, and esophageal cancers. Investors and stakeholders can access the live and archived webcast through Coherus' investor website.

Coherus Oncology's upcoming clinical data disclosure provides context for healthcare sector activity. For readers following health stocks, here is Pluang's market snapshot as of Oct 15, 2026 03:02 WIB: out of 150 priced US health-sector stocks, 90 rose and 60 fell. Notable movers include TMDX at USD 75.65 with a -4.40% change and 100% buy order activity, RPRX at USD 59.02 with a +4.34% change, and UNH at USD 394.00 with a +4.30% change and 70% sell order activity.

More News

Lakefront sells early-stage CAR-T cell therapy programs to Armed Cell Therapeutics for up to $230M plus royalties

Lakefront sells early-stage CAR-T cell therapy programs to Armed Cell Therapeutics for up to $230M plus royalties

Lakefront Biotherapeutics has completed the sale of its preclinical CAR-T cell therapy programs to Belgium-based Armed Cell Therapeutics. The deal includes an upfront payment of €8 million, potential milestone payments up to $230 million, and a low s...

Company Fundamentals
Bullish
41 minutes ago
PNC expects strong Q3 earnings growth despite fee income drop, with mixed operational outlook.

PNC expects strong Q3 earnings growth despite fee income drop, with mixed operational outlook.

PNC Financial Services Group is set to report its Q3 2026 earnings with analysts forecasting earnings of around $4.91 per share and revenue near $6.61 billion, reflecting solid growth. The bank anticipates a 3%–3.5% rise in net interest income and 1%...

Company Fundamentals
Neutral
41 minutes ago
Leonardo DRS wins 10-year NASA SEWP VI contract to supply federal agencies with defense tech through 2036

Leonardo DRS wins 10-year NASA SEWP VI contract to supply federal agencies with defense tech through 2036

Leonardo DRS secured a 10-year prime contract under NASA's SEWP VI program, enabling federal agencies to quickly procure its defense products and services until 2036. This contract extends DRS's role as a SEWP prime contractor, supporting key militar...

Market News
Bullish
42 minutes ago
Honey Badger Silver reports high-grade polymetallic samples at Yava, reviving interest in northern Canada's VMS deposits.

Honey Badger Silver reports high-grade polymetallic samples at Yava, reviving interest in northern Canada's VMS deposits.

Honey Badger Silver announced promising assay results from its first exploration program at the Yava Project in Nunavut, revealing high-grade silver, copper, gold, zinc, and lead samples. This marks the first systematic work at Yava in nearly two dec...

Market News
Bullish
1 hour ago
Top tech leaders from major Minnesota firms to gather at Minneapolis Summit on Oct 27 for AI, cybersecurity, and innovation talks

Top tech leaders from major Minnesota firms to gather at Minneapolis Summit on Oct 27 for AI, cybersecurity, and innovation talks

The 12th Annual Minneapolis C-Level Technology Leadership Summit will take place on October 27 at Interlachen Country Club, Edina, bringing together senior technology executives from leading Minnesota organizations like Cargill, Land O’Lakes, and Blu...

Others
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App